{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:36:09Z","timestamp":1791045369242,"version":"4.1.0"},"reference-count":103,"publisher":"European Respiratory Society (ERS)","issue":"153","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2019,5,8]]},"published-print":{"date-parts":[[2019,9,30]]},"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a dreaded complication of systemic sclerosis (SSc) that occurs in \u223c10% of patients. Most individuals present with severe symptoms, significant functional impairment and severe haemodynamics at diagnosis, and survival after PAH diagnosis is poor. Therefore, early diagnosis through systematic screening of asymptomatic patients has the potential to identify PAH at an early stage. Current evidence suggests that early diagnosis and treatment of PAH in patients with SSc may lead to better clinical outcomes. Annual screening may include echocardiography, but this can miss some patients due to suboptimal visualisation or insufficient tricuspid regurgitation. Other options for screening include the DETECT algorithm or the use of a combination of pulmonary function testing (forced vital capacity\/diffusing capacity of the lung for carbon monoxide ratio) and N-terminal-pro-brain natriuretic peptide levels. Symptomatic patients, those with an elevated tricuspid regurgitation velocity on echocardiogram with or without secondary echocardiographic features of PAH, and those who screen positive on the DETECT or other pulmonary function test algorithms should undergo right heart catheterisation. Exercise echocardiography or cardiopulmonary exercise testing, nailfold capillaroscopy and molecular biomarkers are promising but, as yet, unproven potential options. Future screening studies should employ systematic catheterisation to define the true predictive values for\u00a0PAH.<\/jats:p>","DOI":"10.1183\/16000617.0023-2019","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T15:49:37Z","timestamp":1564588177000},"page":"190023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":89,"title":["Screening for pulmonary arterial hypertension in systemic sclerosis"],"prefix":"10.1183","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-4575","authenticated-orcid":false,"given":"Jason","family":"Weatherald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":false,"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Jevnikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-8975","authenticated-orcid":false,"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2892","authenticated-orcid":false,"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"2024102403402330000_28.153.190023.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01887-2018"},{"key":"2024102403402330000_28.153.190023.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2024102403402330000_28.153.190023.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2024102403402330000_28.153.190023.4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00145608"},{"key":"2024102403402330000_28.153.190023.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1668OC"},{"key":"2024102403402330000_28.153.190023.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"2024102403402330000_28.153.190023.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0676"},{"key":"2024102403402330000_28.153.190023.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1460"},{"key":"2024102403402330000_28.153.190023.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.911818"},{"key":"2024102403402330000_28.153.190023.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00057010"},{"key":"2024102403402330000_28.153.190023.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.898122"},{"key":"2024102403402330000_28.153.190023.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00678-2018"},{"key":"2024102403402330000_28.153.190023.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.11.1088"},{"key":"2024102403402330000_28.153.190023.14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-3014"},{"key":"2024102403402330000_28.153.190023.15","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chest.2018.05.002","article-title":"Long-term outcomes in systemic sclerosis-associated pulmonary arterial hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma registry (PHAROS)","volume":"154","author":"Kolstad","year":"2018","journal-title":"Chest"},{"key":"2024102403402330000_28.153.190023.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200806-953OC"},{"key":"2024102403402330000_28.153.190023.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1820OC"},{"key":"2024102403402330000_28.153.190023.18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-0653"},{"key":"2024102403402330000_28.153.190023.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.344"},{"key":"2024102403402330000_28.153.190023.20","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.109919"},{"key":"2024102403402330000_28.153.190023.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-216"},{"key":"2024102403402330000_28.153.190023.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00465-2017"},{"key":"2024102403402330000_28.153.190023.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00740-2017"},{"key":"2024102403402330000_28.153.190023.24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00092306"},{"key":"2024102403402330000_28.153.190023.25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrcardio.2014.191","article-title":"Early detection of pulmonary arterial hypertension","volume":"12","author":"Lau","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2024102403402330000_28.153.190023.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00522-2017"},{"key":"2024102403402330000_28.153.190023.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192230"},{"key":"2024102403402330000_28.153.190023.28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01904-2018"},{"key":"2024102403402330000_28.153.190023.29","doi-asserted-by":"publisher","DOI":"10.1002\/art.38172"},{"key":"2024102403402330000_28.153.190023.30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0037-1606202","article-title":"Screening of pulmonary arterial hypertension","volume":"38","author":"Lau","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"2024102403402330000_28.153.190023.31","doi-asserted-by":"publisher","DOI":"10.1136\/jms.8.1.1"},{"key":"2024102403402330000_28.153.190023.32","unstructured":"World Health Organization . Cancer. Screening. www.who.int\/cancer\/prevention\/diagnosis-screening\/screening\/en\/ Date last updated: February 3, 2017. Date last accessed: February 5, 2019."},{"key":"2024102403402330000_28.153.190023.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.061"},{"key":"2024102403402330000_28.153.190023.34","doi-asserted-by":"publisher","DOI":"10.1186\/s40985-015-0012-1"},{"key":"2024102403402330000_28.153.190023.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.21433"},{"key":"2024102403402330000_28.153.190023.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091710"},{"key":"2024102403402330000_28.153.190023.37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-017-1250-z","article-title":"Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2024102403402330000_28.153.190023.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2008.01823.x"},{"key":"2024102403402330000_28.153.190023.39","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203301"},{"key":"2024102403402330000_28.153.190023.40","doi-asserted-by":"publisher","DOI":"10.1002\/art.24525"},{"key":"2024102403402330000_28.153.190023.41","doi-asserted-by":"crossref","first-page":"1600227","DOI":"10.1183\/13993003.02275-2016","article-title":"Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort","volume":"49","author":"Vandecasteele","year":"2017","journal-title":"Eur Respir J"},{"key":"2024102403402330000_28.153.190023.42","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024102403402330000_28.153.190023.43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068"},{"key":"2024102403402330000_28.153.190023.44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202489"},{"key":"2024102403402330000_28.153.190023.45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"2024102403402330000_28.153.190023.46","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210236"},{"key":"2024102403402330000_28.153.190023.47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02493-2016"},{"key":"2024102403402330000_28.153.190023.48","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00497-2018"},{"key":"2024102403402330000_28.153.190023.49","doi-asserted-by":"publisher","DOI":"10.1002\/art.30541"},{"key":"2024102403402330000_28.153.190023.50","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.semarthrit.2013.08.002","article-title":"Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review","volume":"43","author":"Gladue","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2024102403402330000_28.153.190023.51","unstructured":"Young A , Nagaraja V , Basilious M , et\u00a0al. Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension. Semin Arthritis Rheum 2018."},{"key":"2024102403402330000_28.153.190023.52","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1691OC"},{"key":"2024102403402330000_28.153.190023.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.07.005"},{"key":"2024102403402330000_28.153.190023.54","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001103"},{"key":"2024102403402330000_28.153.190023.55","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003792"},{"key":"2024102403402330000_28.153.190023.56","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-014-4113-2"},{"key":"2024102403402330000_28.153.190023.57","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10554-018-1299-z","article-title":"Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic sclerosis patients","volume":"34","author":"Hekimsoy","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"2024102403402330000_28.153.190023.58","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350709"},{"key":"2024102403402330000_28.153.190023.59","doi-asserted-by":"publisher","DOI":"10.1002\/art.10775"},{"key":"2024102403402330000_28.153.190023.60","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh067"},{"key":"2024102403402330000_28.153.190023.61","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01008-2017"},{"key":"2024102403402330000_28.153.190023.62","doi-asserted-by":"crossref","first-page":"e78001","DOI":"10.1371\/journal.pone.0078001","article-title":"Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis","volume":"8","author":"Sivova","year":"2013","journal-title":"PLoS One"},{"key":"2024102403402330000_28.153.190023.63","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-9-68"},{"key":"2024102403402330000_28.153.190023.64","doi-asserted-by":"publisher","DOI":"10.1002\/art.27695"},{"key":"2024102403402330000_28.153.190023.65","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2324"},{"key":"2024102403402330000_28.153.190023.66","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01708-2016"},{"key":"2024102403402330000_28.153.190023.67","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201211-2090CI"},{"key":"2024102403402330000_28.153.190023.68","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00021915"},{"key":"2024102403402330000_28.153.190023.69","doi-asserted-by":"publisher","DOI":"10.1002\/art.38043"},{"key":"2024102403402330000_28.153.190023.70","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0673-7"},{"key":"2024102403402330000_28.153.190023.71","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2099"},{"key":"2024102403402330000_28.153.190023.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.05.032"},{"key":"2024102403402330000_28.153.190023.73","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309981"},{"key":"2024102403402330000_28.153.190023.74","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(03)00254-3"},{"key":"2024102403402330000_28.153.190023.75","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi891"},{"key":"2024102403402330000_28.153.190023.76","first-page":"S81","article-title":"Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients","volume":"30","author":"Chighizola","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403402330000_28.153.190023.77","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/acr.22547","article-title":"Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide","volume":"67","author":"Avouac","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024102403402330000_28.153.190023.78","doi-asserted-by":"publisher","DOI":"10.1186\/ar3876"},{"key":"2024102403402330000_28.153.190023.79","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/ar4383","article-title":"The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study","volume":"15","author":"Thakkar","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2024102403402330000_28.153.190023.80","doi-asserted-by":"publisher","DOI":"10.1002\/art.23187"},{"key":"2024102403402330000_28.153.190023.81","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev327"},{"key":"2024102403402330000_28.153.190023.82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-017-1327-8","article-title":"High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center","volume":"19","author":"Castillo A","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2024102403402330000_28.153.190023.83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-015-0517-5","article-title":"A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis","volume":"17","author":"Hao","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2024102403402330000_28.153.190023.84","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp297"},{"key":"2024102403402330000_28.153.190023.85","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200546"},{"key":"2024102403402330000_28.153.190023.86","doi-asserted-by":"publisher","DOI":"10.1002\/art.37838"},{"key":"2024102403402330000_28.153.190023.87","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0493-1"},{"key":"2024102403402330000_28.153.190023.88","doi-asserted-by":"publisher","DOI":"10.1086\/674756"},{"key":"2024102403402330000_28.153.190023.89","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0194"},{"key":"2024102403402330000_28.153.190023.90","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130400"},{"key":"2024102403402330000_28.153.190023.91","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/imj.12890","article-title":"Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis","volume":"45","author":"Quinlivan","year":"2015","journal-title":"Intern Med J"},{"key":"2024102403402330000_28.153.190023.92","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00088.x"},{"key":"2024102403402330000_28.153.190023.93","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087353"},{"key":"2024102403402330000_28.153.190023.94","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket168"},{"key":"2024102403402330000_28.153.190023.95","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mvr.2017.06.005","article-title":"Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension","volume":"114","author":"Corrado","year":"2017","journal-title":"Microvasc Res"},{"key":"2024102403402330000_28.153.190023.96","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.acvd.2015.11.014","article-title":"Prediction of new onset of resting pulmonary arterial hypertension in systemic sclerosis","volume":"109","author":"Voilliot","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"2024102403402330000_28.153.190023.97","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","article-title":"Sequential nailfold video capillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis","volume":"47","author":"Avouac","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2024102403402330000_28.153.190023.98","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.095836"},{"key":"2024102403402330000_28.153.190023.99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/03009742.2010.507217","article-title":"Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease","volume":"40","author":"Hesselstrand","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"2024102403402330000_28.153.190023.100","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep187"},{"key":"2024102403402330000_28.153.190023.101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1532-429X-15-86","article-title":"Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normal \u2013 a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes","volume":"15","author":"Kanski","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024102403402330000_28.153.190023.102","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3389\/fphys.2018.00587","article-title":"Biomarkers for pulmonary vascular remodeling in systemic sclerosis: a pathophysiological approach","volume":"9","author":"Odler","year":"2018","journal-title":"Front Physiol"},{"key":"2024102403402330000_28.153.190023.103","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/art.40534","article-title":"CCL21 as a Potential serum biomarker for pulmonary arterial hypertension in systemic sclerosis","volume":"70","author":"Hoffmann-Vold","year":"2018","journal-title":"Arthritis Rheumatol"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0023-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:01:06Z","timestamp":1740373266000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0023-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":103,"journal-issue":{"issue":"153","published-online":{"date-parts":[[2019,7,31]]},"published-print":{"date-parts":[[2019,9,30]]}},"alternative-id":["10.1183\/16000617.0023-2019"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0023-2019","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]}}}